Castle Biosciences (NasdaqGM:CSTL) Q3 2026 Earnings call November 05, 2026 04:30 PM ET Company Participants Camilla Zuckero - VP of Investor Relations and Corporate Affairs Derek Maetzold - Founder, President, and CEO Frank Stokes - CFO Conference Call Participants Bradley Bowers - Analyst Max Masucci - Analyst None - Analyst Mason Carrico - Analyst Charlotte Maurer - Analyst Matthew Parisi - Analyst Thomas Flaten - Analyst None - Analyst None - Analyst Operator Good afternoon and welcome to Castle Bioscien ...